The Use of SMS Text Messaging to Improve the Hospital-to-Community Transition in Patients With Acute Coronary Syndrome (Txt2Prevent): Results From a Pilot Randomized Controlled Trial.
SMS text messaging
acute coronary syndrome
cardiovascular disease
mHealth
Journal
JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439
Informations de publication
Date de publication:
14 05 2021
14 05 2021
Historique:
received:
23
09
2020
accepted:
11
03
2021
revised:
27
01
2021
entrez:
14
5
2021
pubmed:
15
5
2021
medline:
22
5
2021
Statut:
epublish
Résumé
Acute coronary syndrome (ACS) is a leading cause of hospital admission in North America. Many patients with ACS experience challenges after discharge that impact their clinical outcomes and psychosocial well-being. SMS text messaging has the potential to provide support to patients during this postdischarge period. This study pilot tested a 60-day SMS text messaging intervention (Txt2Prevent) for patients with ACS. The primary objective was to compare self-management domains between usual care and usual care plus Txt2Prevent. The secondary objectives were to compare medication adherence, health-related quality of life, self-efficacy, and health care resource use between groups. The third objective was to assess the feasibility of the study protocol and the acceptability of the intervention. This was a randomized controlled trial with blinding of outcome assessors. We recruited 76 patients with ACS from St. Paul's Hospital in Vancouver, Canada, and randomized them to 1 of 2 groups within 7 days of discharge. The Txt2Prevent program included automated 1-way SMS text messages about follow-up care, self-management, and healthy living. Data were collected during the index admission and at 60 days after randomization. The primary outcome was measured with the Health Education Impact Questionnaire (heiQ). Other outcomes included the EQ-5D-5L, EQ-5D-5L Visual Analog Scale, a modified Sullivan Cardiac Self-Efficacy Scale, and Morisky Medication Adherence Scale scores, and self-reported health care resource use. Analyses of covariance were used to test the effect of group assignment on follow-up scores (controlling for baseline) and were considered exploratory in nature. Feasibility was assessed with descriptive characteristics of the study protocol. Acceptability was assessed with 2 survey questions and semistructured interviews. There were no statistically significant differences between the groups for the heiQ domains (adjusted mean difference [Txt2Prevent minus usual care] for each domain-Health-directed activity: -0.13, 95% CI -0.39 to 0.13, P=.31; Positive and active engagement in life: 0.03, 95% CI -0.19 to 0.25, P=.76; Emotional distress: 0.04, 95% CI -0.22 to 0.29, P=.77; Self-monitoring and insight: -0.14, 95% CI -0.33 to 0.05, P=.15; Constructive attitudes and approaches: -0.10, 95% CI -0.36 to 0.17, P=.47; Skill technique and acquisition: 0.05, 95% CI -0.18 to 0.27, P=.69; Social integration and support: -0.12, 95% CI -0.34 to 0.10, P=.27; and Health services navigation: -0.05, 95% CI -0.29 to 0.19, P=.69). For the secondary outcomes, there were no statistically significant differences in adjusted analyses except in 1 self-efficacy domain (Total plus), where the Txt2Prevent group had lower scores (mean difference -0.36, 95% CI -0.66 to -0.50, P=.03). The study protocol was feasible, but recruitment took longer than expected. Over 90% (29/31 [94%]) of participants reported they were satisfied with the program. The Txt2Prevent study was feasible to implement; however, although exploratory, there were no differences between the 2 groups in adjusted analyses except for 1 self-efficacy domain. As the intervention appeared acceptable, there is potential in using SMS text messages in this context. The design of the intervention may need to be reconsidered to have more impact on outcome measures. ClinicalTrials.gov NCT02336919; https://clinicaltrials.gov/ct2/show/NCT02336919. RR2-10.2196/resprot.6968.
Sections du résumé
BACKGROUND
Acute coronary syndrome (ACS) is a leading cause of hospital admission in North America. Many patients with ACS experience challenges after discharge that impact their clinical outcomes and psychosocial well-being. SMS text messaging has the potential to provide support to patients during this postdischarge period.
OBJECTIVE
This study pilot tested a 60-day SMS text messaging intervention (Txt2Prevent) for patients with ACS. The primary objective was to compare self-management domains between usual care and usual care plus Txt2Prevent. The secondary objectives were to compare medication adherence, health-related quality of life, self-efficacy, and health care resource use between groups. The third objective was to assess the feasibility of the study protocol and the acceptability of the intervention.
METHODS
This was a randomized controlled trial with blinding of outcome assessors. We recruited 76 patients with ACS from St. Paul's Hospital in Vancouver, Canada, and randomized them to 1 of 2 groups within 7 days of discharge. The Txt2Prevent program included automated 1-way SMS text messages about follow-up care, self-management, and healthy living. Data were collected during the index admission and at 60 days after randomization. The primary outcome was measured with the Health Education Impact Questionnaire (heiQ). Other outcomes included the EQ-5D-5L, EQ-5D-5L Visual Analog Scale, a modified Sullivan Cardiac Self-Efficacy Scale, and Morisky Medication Adherence Scale scores, and self-reported health care resource use. Analyses of covariance were used to test the effect of group assignment on follow-up scores (controlling for baseline) and were considered exploratory in nature. Feasibility was assessed with descriptive characteristics of the study protocol. Acceptability was assessed with 2 survey questions and semistructured interviews.
RESULTS
There were no statistically significant differences between the groups for the heiQ domains (adjusted mean difference [Txt2Prevent minus usual care] for each domain-Health-directed activity: -0.13, 95% CI -0.39 to 0.13, P=.31; Positive and active engagement in life: 0.03, 95% CI -0.19 to 0.25, P=.76; Emotional distress: 0.04, 95% CI -0.22 to 0.29, P=.77; Self-monitoring and insight: -0.14, 95% CI -0.33 to 0.05, P=.15; Constructive attitudes and approaches: -0.10, 95% CI -0.36 to 0.17, P=.47; Skill technique and acquisition: 0.05, 95% CI -0.18 to 0.27, P=.69; Social integration and support: -0.12, 95% CI -0.34 to 0.10, P=.27; and Health services navigation: -0.05, 95% CI -0.29 to 0.19, P=.69). For the secondary outcomes, there were no statistically significant differences in adjusted analyses except in 1 self-efficacy domain (Total plus), where the Txt2Prevent group had lower scores (mean difference -0.36, 95% CI -0.66 to -0.50, P=.03). The study protocol was feasible, but recruitment took longer than expected. Over 90% (29/31 [94%]) of participants reported they were satisfied with the program.
CONCLUSIONS
The Txt2Prevent study was feasible to implement; however, although exploratory, there were no differences between the 2 groups in adjusted analyses except for 1 self-efficacy domain. As the intervention appeared acceptable, there is potential in using SMS text messages in this context. The design of the intervention may need to be reconsidered to have more impact on outcome measures.
TRIAL REGISTRATION
ClinicalTrials.gov NCT02336919; https://clinicaltrials.gov/ct2/show/NCT02336919.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
RR2-10.2196/resprot.6968.
Identifiants
pubmed: 33988519
pii: v9i5e24530
doi: 10.2196/24530
pmc: PMC8164115
doi:
Banques de données
ClinicalTrials.gov
['NCT02336919']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e24530Subventions
Organisme : CIHR
ID : 316822
Pays : Canada
Informations de copyright
©Emily S Ross, Brodie M Sakakibara, Martha H Mackay, David G T Whitehurst, Joel Singer, Mustafa Toma, Kitty K Corbett, Harriette G C Van Spall, Kimberly Rutherford, Bobby Gheorghiu, Jillianne Code, Scott A Lear. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 14.05.2021.
Références
Arch Intern Med. 2004 Apr 12;164(7):733-40
pubmed: 15078642
Int J Nurs Stud. 2016 Sep;61:29-51
pubmed: 27267181
BMC Cardiovasc Disord. 2016 Jul 08;16(1):144
pubmed: 27391321
Am J Manag Care. 2009 Jan;15(1):59-66
pubmed: 19146365
Cochrane Database Syst Rev. 2017 Apr 29;4:CD011851
pubmed: 28455948
J Med Internet Res. 2015 Mar 03;17(3):e53
pubmed: 25736340
J Am Heart Assoc. 2014 Sep 18;3(5):e001046
pubmed: 25237046
Psychosom Med. 1998 Jul-Aug;60(4):473-8
pubmed: 9710293
J Clin Epidemiol. 2011 Mar;64(3):255-7; discussion 258-63
pubmed: 21144706
J Adv Nurs. 2000 Dec;32(6):1403-11
pubmed: 11136408
JAMA Cardiol. 2016 Aug 1;1(5):601-6
pubmed: 27438754
Digit Health. 2019 Apr 22;5:2055207619845279
pubmed: 31041110
Medicine (Baltimore). 2019 Feb;98(8):e14596
pubmed: 30813183
Eur J Cardiovasc Nurs. 2015 Apr;14(2):170-9
pubmed: 24491349
Prog Cardiovasc Dis. 2016 May-Jun;58(6):605-12
pubmed: 26902519
Circulation. 2010 Feb 16;121(6):750-8
pubmed: 20124123
Circ Cardiovasc Qual Outcomes. 2019 Apr;12(4):e005616
pubmed: 30998400
Qual Life Res. 2005 Mar;14(2):285-95
pubmed: 15892420
Eur J Cardiovasc Nurs. 2005 Mar;4(1):37-44
pubmed: 15718191
Circulation. 2016 Jan 26;133(4):e38-360
pubmed: 26673558
Am J Epidemiol. 2003 May 15;157(10):940-3
pubmed: 12746247
Patient Educ Couns. 2007 May;66(2):192-201
pubmed: 17320338
JAMA Intern Med. 2016 Mar;176(3):340-9
pubmed: 26831740
Heart. 2006 Jan;92(1):62-7
pubmed: 15797936
Heart Lung. 2018 Jul - Aug;47(4):351-359
pubmed: 29803297
Med Care. 2003 Jun;41(6):706-15
pubmed: 12773836
Qual Life Res. 2013 Sep;22(7):1717-27
pubmed: 23184421
JMIR Mhealth Uhealth. 2014 Dec 11;2(4):e52
pubmed: 25499592
Soc Sci Med. 2013 Nov;97:41-8
pubmed: 24161087
Eur J Cardiovasc Nurs. 2009 Sep;8(3):190-9
pubmed: 19162553
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
JAMA Cardiol. 2016 May 1;1(2):147-55
pubmed: 27437885
Arch Intern Med. 2008 Mar 10;168(5):485-91; discussion 492
pubmed: 18332293
Eur J Prev Cardiol. 2014 Apr;21(4):492-9
pubmed: 22605787
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
Pediatr Rheumatol Online J. 2017 Oct 13;15(1):75
pubmed: 29029616
Open Heart. 2019 Oct 9;6(2):e001017
pubmed: 31673381
J Adv Nurs. 2014 Sep;70(9):1932-1953
pubmed: 24689978
PLoS One. 2017 Jan 27;12(1):e0170061
pubmed: 28129332
Circulation. 2008 Feb 26;117(8):1028-36
pubmed: 18299512
Iran J Nurs Midwifery Res. 2016 Mar-Apr;21(2):171-6
pubmed: 27095991
Med Care. 2016 Jan;54(1):98-105
pubmed: 26492214
Circulation. 2014 Dec 23;130(25):e344-426
pubmed: 25249585
J Am Heart Assoc. 2017 Oct 4;6(10):
pubmed: 28978528
J Am Coll Cardiol. 2014 Dec 23;64(24):e139-e228
pubmed: 25260718
Age Ageing. 2005 Jul;34(4):338-43
pubmed: 15955757
JMIR Res Protoc. 2017 May 23;6(5):e91
pubmed: 28536088
BMJ. 2015 Feb 05;350:h411
pubmed: 25656852
Int J Cardiol. 2013 Sep 20;168(1):568-9
pubmed: 23462636
J Am Heart Assoc. 2017 Oct 19;6(10):
pubmed: 29051213
J Clin Hypertens (Greenwich). 2008 May;10(5):348-54
pubmed: 18453793
Contemp Clin Trials Commun. 2018 May 04;11:75-82
pubmed: 29998203
JAMA. 2015 Sep 22-29;314(12):1255-63
pubmed: 26393848
J Med Internet Res. 2011 Dec 31;13(4):e126
pubmed: 22209829
J Adv Nurs. 2001 Jun;34(6):787-94
pubmed: 11422549
BMC Health Serv Res. 2014 Aug 27;14:356
pubmed: 25164529
JAMA. 2013 Jan 23;309(4):355-63
pubmed: 23340637
BMC Health Serv Res. 2012 Aug 16;12:259
pubmed: 22897912
Patient Educ Couns. 2014 Feb;94(2):261-8
pubmed: 24321403
Eur J Prev Cardiol. 2015 Jun;22(6):701-9
pubmed: 24817694
Can J Cardiol. 2010 Mar;26(3):129-34
pubmed: 20352132
Telemed J E Health. 2017 Mar;23(3):233-239
pubmed: 27623231